151 related articles for article (PubMed ID: 10527847)
1. Inhibition of adipogenesis by a COOH-terminally truncated mutant of PPARgamma2 in 3T3-L1 cells.
Masugi J; Tamori Y; Kasuga M
Biochem Biophys Res Commun; 1999 Oct; 264(1):93-9. PubMed ID: 10527847
[TBL] [Abstract][Full Text] [Related]
2. A selective peroxisome proliferator-activated receptor-gamma (PPARgamma) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes.
Mukherjee R; Hoener PA; Jow L; Bilakovics J; Klausing K; Mais DE; Faulkner A; Croston GE; Paterniti JR
Mol Endocrinol; 2000 Sep; 14(9):1425-33. PubMed ID: 10976920
[TBL] [Abstract][Full Text] [Related]
3. Role of peroxisome proliferator-activated receptor-gamma in maintenance of the characteristics of mature 3T3-L1 adipocytes.
Tamori Y; Masugi J; Nishino N; Kasuga M
Diabetes; 2002 Jul; 51(7):2045-55. PubMed ID: 12086932
[TBL] [Abstract][Full Text] [Related]
4. Differential gene regulation by PPARgamma agonist and constitutively active PPARgamma2.
Li Y; Lazar MA
Mol Endocrinol; 2002 May; 16(5):1040-8. PubMed ID: 11981038
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis.
Masugi J; Tamori Y; Mori H; Koike T; Kasuga M
Biochem Biophys Res Commun; 2000 Feb; 268(1):178-82. PubMed ID: 10652233
[TBL] [Abstract][Full Text] [Related]
6. The short- and long-term effects of tumor necrosis factor-alpha and BRL 49653 on peroxisome proliferator-activated receptor (PPAR)gamma2 gene expression and other adipocyte genes.
Rosenbaum SE; Greenberg AS
Mol Endocrinol; 1998 Aug; 12(8):1150-60. PubMed ID: 9717841
[TBL] [Abstract][Full Text] [Related]
7. Counteraction of retinoic acid and 1,25-dihydroxyvitamin D3 on up-regulation of adipocyte differentiation with PPARgamma ligand, an antidiabetic thiazolidinedione, in 3T3-L1 cells.
Hida Y; Kawada T; Kayahashi S; Ishihara T; Fushiki T
Life Sci; 1998; 62(14):PL205-11. PubMed ID: 9570344
[TBL] [Abstract][Full Text] [Related]
8. Pioglitazone ameliorates tumor necrosis factor-alpha-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator--activated receptor-gamma.
Iwata M; Haruta T; Usui I; Takata Y; Takano A; Uno T; Kawahara J; Ueno E; Sasaoka T; Ishibashi O; Kobayashi M
Diabetes; 2001 May; 50(5):1083-92. PubMed ID: 11334412
[TBL] [Abstract][Full Text] [Related]
9. The farnesoid X receptor promotes adipocyte differentiation and regulates adipose cell function in vivo.
Rizzo G; Disante M; Mencarelli A; Renga B; Gioiello A; Pellicciari R; Fiorucci S
Mol Pharmacol; 2006 Oct; 70(4):1164-73. PubMed ID: 16778009
[TBL] [Abstract][Full Text] [Related]
10. Thiazolidinedione- and tumor necrosis factor alpha-induced downregulation of peroxisome proliferator-activated receptor gamma mRNA in differentiated 3T3-L1 adipocytes.
Perrey S; Ishibashi S; Yahagi N; Osuga J; Tozawa R; Yagyu H; Ohashi K; Gotoda T; Harada K; Chen Z; Iizuka Y; Shionoiri F; Yamada N
Metabolism; 2001 Jan; 50(1):36-40. PubMed ID: 11172472
[TBL] [Abstract][Full Text] [Related]
11. Stage-specific effects of a thiazolidinedione on proliferation, differentiation and PPARgamma mRNA expression in 3T3-L1 adipocytes.
Takamura T; Nohara E; Nagai Y; Kobayashi K
Eur J Pharmacol; 2001 Jun; 422(1-3):23-9. PubMed ID: 11430909
[TBL] [Abstract][Full Text] [Related]
12. A novel potent antagonist of peroxisome proliferator-activated receptor gamma blocks adipocyte differentiation but does not revert the phenotype of terminally differentiated adipocytes.
Camp HS; Chaudhry A; Leff T
Endocrinology; 2001 Jul; 142(7):3207-13. PubMed ID: 11416043
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor-gamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells.
Gimble JM; Robinson CE; Wu X; Kelly KA; Rodriguez BR; Kliewer SA; Lehmann JM; Morris DC
Mol Pharmacol; 1996 Nov; 50(5):1087-94. PubMed ID: 8913339
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of glucose uptake in 3T3-L1 adipocytes by PPAR gamma agonists is maintained in cells expressing a PPAR gamma dominant-negative mutant: evidence for selectivity in the downstream responses to PPAR gamma activation.
Nugent C; Prins JB; Whitehead JP; Savage D; Wentworth JM; Chatterjee VK; O'Rahilly S
Mol Endocrinol; 2001 Oct; 15(10):1729-38. PubMed ID: 11579205
[TBL] [Abstract][Full Text] [Related]
15. A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis.
Gurnell M; Wentworth JM; Agostini M; Adams M; Collingwood TN; Provenzano C; Browne PO; Rajanayagam O; Burris TP; Schwabe JW; Lazar MA; Chatterjee VK
J Biol Chem; 2000 Feb; 275(8):5754-9. PubMed ID: 10681562
[TBL] [Abstract][Full Text] [Related]
16. A novel 3T3-L1 preadipocyte variant that expresses PPARgamma2 and RXRalpha but does not undergo differentiation.
Baillie RA; Sha X; Thuillier P; Clarke SD
J Lipid Res; 1998 Oct; 39(10):2048-53. PubMed ID: 9788251
[TBL] [Abstract][Full Text] [Related]
17. Induction of the nuclear orphan receptor RORgamma during adipocyte differentiation of D1 and 3T3-L1 cells.
Austin S; Medvedev A; Yan ZH; Adachi H; Hirose T; Jetten AM
Cell Growth Differ; 1998 Mar; 9(3):267-76. PubMed ID: 9543393
[TBL] [Abstract][Full Text] [Related]
18. Use of a PPAR gamma-specific monoclonal antibody to demonstrate thiazolidinediones induce PPAR gamma receptor expression in vitro.
Su JL; Winegar DA; Wisely GB; Sigel CS; Hull-Ryde EA
Hybridoma; 1999 Jun; 18(3):273-80. PubMed ID: 10475242
[TBL] [Abstract][Full Text] [Related]
19. A peroxisome proliferator-response element in the murine mc2-r promoter regulates its transcriptional activation during differentiation of 3T3-L1 adipocytes.
Noon LA; Clark AJ; King PJ
J Biol Chem; 2004 May; 279(22):22803-8. PubMed ID: 15028712
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of adult primitive mesenchymal ST-13 preadipocyte differentiation.
Yajima Y; Sato M; Sumida M; Kawashima S
Endocrinology; 2003 Jun; 144(6):2559-65. PubMed ID: 12746319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
